Literature DB >> 18542033

Recommendations for probiotic use--2008.

Martin H Floch1, W Allan Walker, Stefano Guandalini, Patricia Hibberd, Sherwood Gorbach, Christina Surawicz, Mary Ellen Sanders, Guadalupe Garcia-Tsao, Eamonn M M Quigley, Erika Isolauri, Richard N Fedorak, Levinus A Dieleman.   

Abstract

Recommendations for the clinical use of probiotics were published after a Yale University Workshop in 2005. A similar workshop was held in 2007, and the recommendations were updated and extended into other areas. The recommendations are graded into an "A," "B," "C" or no category based on the expert's opinion and review by the workshop participants. An "A" recommendation is made for acute childhood diarrhea, prevention of antibiotic-associated diarrhea, preventing and maintaining remission in pouchitis, and in an immune response for the treatment and prevention of atopic eczema associated with cow's milk allergy. The group maintained several "B" recommendations in other areas of treating inflammatory bowel disease and irritable bowel syndrome. Although there are significant studies in the "B" group, most "B" recommendations did not reach an "A" level because of some negative studies or a limited number of studies. Many reports in the "C" recommendations were significant but fell short of receiving stronger ratings because of the size of reported patient studies, and also the factors that limited categories to the "B" rating.

Entities:  

Mesh:

Year:  2008        PMID: 18542033     DOI: 10.1097/MCG.0b013e31816b903f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  27 in total

Review 1.  Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics.

Authors:  Michele Caselli; Giuseppina Vaira; Girolamo Calo; Francesco Papini; John Holton; Dino Vaira
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

2.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

3.  How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  MaryBeth Mercer; Margaret A Brinich; Gail Geller; Krista Harrison; Janelle Highland; Katherine James; Patricia Marshall; Jennifer B McCormick; Jon Tilburt; Jean-Paul Achkar; Ruth M Farrell; Richard R Sharp
Journal:  J Clin Gastroenterol       Date:  2012-02       Impact factor: 3.062

Review 4.  Radiation enteritis.

Authors:  Ali H Harb; Carla Abou Fadel; Ala I Sharara
Journal:  Curr Gastroenterol Rep       Date:  2014

5.  Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.

Authors:  Michael D Williams; Christina Y Ha; Matthew A Ciorba
Journal:  J Clin Gastroenterol       Date:  2010-10       Impact factor: 3.062

6.  Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.

Authors:  Teemu J Taipale; Kaisu Pienihäkkinen; Erika Isolauri; Jorma T Jokela; Eva M Söderling
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

7.  Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection.

Authors:  Mary Hickson
Journal:  Therap Adv Gastroenterol       Date:  2011-05       Impact factor: 4.409

Review 8.  Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.

Authors:  David S Kotlyar; Mili Shum; Jennifer Hsieh; Wojciech Blonski; David A Greenwald
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 9.  Irritable bowel syndrome: a concise review of current treatment concepts.

Authors:  Geoffrey C Wall; Ginelle A Bryant; Michelle M Bottenberg; Erik D Maki; Andrew R Miesner
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.